Beclometasone 100 Cyclocaps Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

beclometasone 100 cyclocaps

teva uk ltd - beclometasone dipropionate - inhalation powder - 100microgram

Beclometasone 200 Cyclocaps Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

beclometasone 200 cyclocaps

teva uk ltd - beclometasone dipropionate - inhalation powder - 200microgram

Beclometasone 400 Cyclocaps Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

beclometasone 400 cyclocaps

teva uk ltd - beclometasone dipropionate - inhalation powder - 400microgram

FOSTER NEXTHALER INHALATION POWDER 100 MCG6 MCG PER DOSE Singapour - anglais - HSA (Health Sciences Authority)

foster nexthaler inhalation powder 100 mcg6 mcg per dose

orient europharma pte ltd - beclometasone dipropionate anhydrous (micronized); formoterol fumarate dihydrate (micronized) - powder, metered - beclometasone dipropionate anhydrous (micronized) 100mcg/dose; formoterol fumarate dihydrate (micronized) 6mcg/dose

BECONASE AQUEOUS 50 Mcg/Acutuation Nasal Spray Suspension Irlande - anglais - HPRA (Health Products Regulatory Authority)

beconase aqueous 50 mcg/acutuation nasal spray suspension

glaxosmithkline (ireland) limited - beclometasone dipropionate - nasal spray suspension - 50 mcg/acutuation

FOSTER 1006 Israël - anglais - Ministry of Health

foster 1006

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.copd :symptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

Aldecin Aqueous Nasal Spray Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

aldecin aqueous nasal spray

schering-plough a division of schering-plough animal health limited - beclometasone dipropionate 0.42 mg/g equivalent to 50 µg/dose - nasal spray solution - 50 mcg/dose - active: beclometasone dipropionate 0.42 mg/g equivalent to 50 µg/dose excipient: benzalkonium chloride as 50% solution citric acid monohydrate dispersible cellulose as avicel rc-591 glycerol polysorbate 80 propylene glycol purified water sodium citrate dihydrate

Aldecin Hayfever Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

aldecin hayfever

schering-plough a division of schering-plough animal health limited - beclometasone dipropionate 0.42 mg/g equivalent to 50 µg/dose - nasal spray solution - 50 mcg/dose - active: beclometasone dipropionate 0.42 mg/g equivalent to 50 µg/dose excipient: benzalkonium chloride citric acid monohydrate dispersible cellulose glycerol polysorbate 80 propylene glycol purified water sodium citrate dihydrate